Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
WULING MOTORS | 6LY | Jun 24, 2024 | 0.04 | -5.37 |
Wuxi Biologics (Cayman) Inc American Depositary Receipts - U | 1FW1 | Jun 24, 2024 | 2.74 | +3.01 |
Wuxi Biologics (Cayman) Inc. | 1FW2 | Jun 24, 2024 | 1.40 | +2.62 |
WUXI XDC O.N. | L74 | Jun 24, 2024 | 2.04 | 0.00 |
WW International, Inc. | WW6 | Jun 24, 2024 | 1.10 | -0.20 |
Wyld Networks AB | 7HW | Jun 24, 2024 | 0.09 | 0.00 |
Wyndham Hotels & Resorts, Inc. | 2WY | Jun 24, 2024 | 68.50 | +1.48 |
WYNN MACAU | 8WY | Jun 24, 2024 | 0.73 | -1.61 |
Wynn Macau Ltd | 8WY0 | Jun 24, 2024 | 7.10 | -2.07 |
Wynn Resorts, Limited | WYR | Jun 24, 2024 | 82.97 | -0.60 |
Wynnstay Group | 80Y | Jun 24, 2024 | 4.32 | +0.47 |
Wärtsilä B | MTA | Jun 24, 2024 | 18.27 | -0.95 |
Wästbygg | WAA | Jun 24, 2024 | 4.44 | +1.60 |
X-FAB Silicon Foundries SE | XFB | Jun 24, 2024 | 6.16 | -1.91 |
X1 Entertainment Group Inc | QN9 | Jun 24, 2024 | 0.22 | +3.77 |
X4 Pharmaceuticals, Inc. | 48Q | Jun 24, 2024 | 0.92 | +5.78 |
Xaar | XAR | Jun 24, 2024 | 1.67 | -1.76 |
Xali Gold Corp | I970 | Jun 24, 2024 | 0.02 | 0.00 |
Xander Resources | 1XI0 | Jun 24, 2024 | 0.03 | +11.86 |
Xano Industrier AB | F4E | Jun 24, 2024 | 7.14 | -4.67 |
XBiotech Inc | 4XB | Jun 24, 2024 | 4.68 | +0.86 |
Xbrane Biopharma | 7XB | Jun 24, 2024 | 0.02 | 0.00 |
Xcel Energy Inc. | NRN | Jun 24, 2024 | 50.26 | +0.52 |
XD Inc. | 3OE | Jun 24, 2024 | 2.24 | -5.88 |
XEBRA BRANDS CL.A | 9YC0 | Jun 24, 2024 | 0.05 | -7.08 |
Xencor, Inc. | XE9 | Jun 24, 2024 | 18.20 | +2.25 |
Xenia Hotels & Resorts, Inc. | 0XHR | Jun 24, 2024 | 13.10 | -0.76 |
Xenon Pharmaceuticals Inc. - | XP0 | Jun 24, 2024 | 35.00 | +1.16 |
Xeris Biopharma Holdings Inc | 2B30 | Jun 24, 2024 | 1.93 | +0.94 |
Xero Limited | 0XE | Jun 24, 2024 | 79.00 | -0.63 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.